VANGUARD GROUP INC 13D and 13G filings for OPKO Health, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 4:54 pm Unchanged |
2024-09-30 | 13G | OPKO Health, Inc. OPK |
VANGUARD GROUP INC | 29,218,150 4.180% |
0 (Unchanged) |
Filing |
| 2024-11-04 1:24 pm Sale |
2024-09-30 | 13G | OPKO Health, Inc. OPK |
VANGUARD GROUP INC | 29,218,150 4.180% |
-10,533,143 (-26.50%) |
Filing |
| 2024-02-13 5:12 pm Sale |
2023-12-29 | 13G | OPKO Health, Inc. OPK |
VANGUARD GROUP INC | 39,751,293 5.140% |
-1,369,201 (-3.33%) |
Filing |
| 2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | OPKO Health, Inc. OPK |
VANGUARD GROUP INC | 41,120,494 5.320% |
5,395,070 (+15.10%) |
Filing |
| 2022-02-10 08:28 am Purchase |
2021-12-31 | 13G | OPKO Health, Inc. OPK |
VANGUARD GROUP INC | 35,725,424 5.240% |
1,275,270 (+3.70%) |
Filing |
| 2021-02-10 11:40 am Sale |
2020-12-31 | 13G | OPKO Health, Inc. OPK |
VANGUARD GROUP INC | 34,450,154 5.140% |
-3,094,496 (-8.24%) |
Filing |